Vision-related quality of life in persons with unilateral branch retinal vein occlusion using the 25-item National Eye Institute Visual Function Questionnaire

2009 ◽  
Vol 94 (3) ◽  
pp. 319-323 ◽  
Author(s):  
R. M Awdeh ◽  
S. H Elsing ◽  
V. A Deramo ◽  
S. Stinnett ◽  
P. P Lee ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Retinal Vein Occlusion ◽  
Visual Function ◽  
Branch Retinal Vein Occlusion ◽  
Vein Occlusion ◽  
Related Quality ◽  
Visual Function Questionnaire

scholarly journals Time Course of Changes in Vision-Related Quality of Life following Intravitreal Ranibizumab Treatment for Branch Retinal Vein Occlusion

2021 ◽  
Author(s):  
Shohei Morikawa ◽  
Fumiki Okamoto ◽  
Tomoya Murakami ◽  
Yoshimi Sugiura ◽  
Takahiro Hiraoka ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Retinal Vein Occlusion ◽  
Branch Retinal Vein Occlusion ◽  
Healthy Subjects ◽  
Composite Score ◽  
Intravitreal Ranibizumab ◽  
Near Vision ◽  
Vein Occlusion ◽  
Related Quality

Abstract Purpose: To assess the vision-related quality of life (VR-QOL) following intravitreal ranibizumab (IVR) for branch retinal vein occlusion (BRVO) and to evaluate subscale items of the VR-QOL.Methods: In this prospective observational multicenter study, 38 patients who underwent IVR treatment for unilateral BRVO and 28 age-matched healthy subjects were chosen. The 25-item National Eye Institute Visual Function Questionnaire (VFQ-25) and best-corrected visual acuity (BCVA) were examined before and at 3, 6, and 12 months after treatment.Results: The VFQ-25 composite score and BCVA significantly improved from 3 to 12 months after IVR treatment (P < 0.05), such that there was no significant difference between the BRVO and control groups at 12 months. All subscales of the VFQ-25, except “general health,” significantly improved after treatment, while “near vision” and “mental health” were worse than those in healthy subjects (P < 0.05). Patients with superior BRVO had a lower “near vision” score than healthy subjects after treatment (P < 0.05). BCVA in the treated eye and fellow eye had no significant relationship with the VFQ-25 composite score before and after treatment.Conclusions: The VR-QOL of patients with BRVO improved with IVR treatment and was comparable to that of healthy subjects after 12 months. Superior BRVO particularly affected near vision for a low level.

scholarly journals Vision-Related Quality of Life and Subscale Items Following Intravitreal Ranibizumab Injections for Central Retinal Vein Occlusion

2021 ◽  
Author(s):  
Fumiki Okamoto ◽  
Tomoya Murakami ◽  
Yoshimi Sugiura ◽  
Shohei Morikawa ◽  
Takahiro Hiraoka ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Central Retinal Vein Occlusion ◽  
Visual Function ◽  
Intravitreal Ranibizumab ◽  
Vein Occlusion ◽  
Before And After ◽  
Related Quality ◽  
Normal Controls ◽  
Central Retinal Vein

Abstract The aim of this study was to evaluate the vision-related quality of life (VR-QOL) before and after intravitreal ranibizumab injections (IVR) for central retinal vein occlusion (CRVO) and investigate subscale items of VR-QOL in detail. This multicenter, open-label, prospective study included 23 patients with treatment naïve CRVO and 22 age-matched normal controls. VR-QOL was assessed by the 25-Item Visual Function Questionnaire (VFQ-25) before and up to 12 months post-treatment. The VFQ-25 composite score and 12 subscales were compared between groups. The VFQ-25 composite scores in CRVO showed significant improvement throughout the treatment period compared with those at the baseline. The VFQ-25 composite score before and after treatment in CRVO was significantly lower than that in normal controls. The subscale items, including general health, general vision, near activities, social functioning, mental health, role difficulties, dependency, and peripheral vision, in CRVO were significantly lower than those in the normal controls even after treatment. Vision-related QOL was low in patients with CRVO before treatment and improved with IVR. Even after treatment, the values of several subscale items were lower than those in normal controls. Patients with CRVO require treatment aimed at further improving visual function as well as social and psychological care.

scholarly journals Psychometric Properties of the Croatian Version of the 25-item National Eye Institute Visual Function Questionnaire (NEI VFQ-25)

2021 ◽  
Author(s):  
Dina Lešin Gaćina ◽  
Bernarda Škegro ◽  
Sonja Jandroković ◽  
Ivan Škegro ◽  
Iva Bešlić ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Visual Impairment ◽  
Psychometric Properties ◽  
Visual Function ◽  
Discriminant Validity ◽  
Ophthalmological Examination ◽  
Sf 36 ◽  
Related Quality ◽  
Visual Function Questionnaire

Abstract Purpose: The purpose of study was to translate, adapt and validate the Croatian version of the 25-item National Eye Institute Visual Function Questionnaire (NEI VFQ-25) in participants with visual impairment. This study also aims at evaluating the relationship between visual impairment and health-related quality of life (HRQoL).Methods: The prospective observational study was conducted at the University Hospital Centre Zagreb, Department of Ophthalmology. The sample consisted of 175 patients with four chronic ocular diseases: cataract, glaucoma, diabetic retinopathy and age-related macular degeneration (ARMD). The translation of the NEI VFQ-25 to Croatian was conducted following the standardized procedure. All participants underwent an ophthalmological examination and completed the NEI VFQ-25 and the Medical Outcomes Study Short Form-36 Questionnaire (SF-36). In order to assess the psychometric properties of the NEI VFQ-25 we calculated Cronbach's α coefficient, intraclass correlation coefficient (ICC), convergent and discriminant validity, as well as criterion and concurrent validity.Results: Results show high internal consistency (Cronbach α range 0.739-0.932) and high test-retest reliability (ICC 0.876-0.975) for all subscales. None of the items had failed either convergent or discriminant validity. Moderate to high Spearman's rho coefficients of correlations were found between best corrected visual acuity and 8 subscales in the NEI VFQ-25 (0.430<ρ<0.631). Moderate correlations were found between comparable domains in the NEI VFQ-25 and in the SF-36 questionnaire (p<0.01).Conclusion: The Croatian version of the NEI VFQ-25 has very good psychometric properties and can be a useful instrument for assessing vision-related quality of life in Croatian population with chronic ophthalmic diseases. The trial registration number: DRKS-ID DRKS00016751Date of registration in DRKS: 2019/02/15

scholarly journals Relationship between stereopsis and vision-related quality of life following intravitreal ranibizumab injections for central retinal vein occlusion

2021 ◽  
Vol 11 (1) ◽  
Author(s):  
Fumiki Okamoto ◽  
Mizuki Tomioka ◽  
Tomoya Murakami ◽  
Shohei Morikawa ◽  
Yoshimi Sugiura ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Visual Acuity ◽  
Retinal Vein Occlusion ◽  
Central Retinal Vein Occlusion ◽  
Post Treatment ◽  
Intravitreal Ranibizumab ◽  
Vein Occlusion ◽  
Related Quality ◽  
Central Retinal Vein

AbstractThe study aimed to evaluate changes in stereopsis and vision-related quality of life (VR-QOL) in patients with central retinal vein occlusion (CRVO) following intravitreal ranibizumab injection (IVR) and investigate the relationship between stereopsis and VR-QOL. This study included 23 treatment-naïve patients with non-ischemic CRVO and 13 age-matched normal controls. Stereopsis, best-corrected visual acuity (BCVA), VR-QOL, and retinal microstructures were examined pre-treatment and 12 months post-treatment. The Titmus Stereo Test (TST) and TNO stereotest (TNO) were used to evaluate stereopsis. VR-QOL was evaluated using the 25-item National Eye Institute Visual Function Questionnaire (VFQ-25). IVR immediately and significantly improved the TST values, TNO values, composite VFQ-25 score, BCVA, and central foveal thickness in patients with CRVO. The 12-month post-treatment TST and TNO values were significantly worse in the CRVO group compared to those in the normal group. At the baseline, the composite VFQ-25 score significantly correlated only with the TST value. Multivariate analysis revealed significant associations between the 12-month post-treatment composite VFQ-25 score and the baseline and 12-month post-treatment TNO values. In conclusion, IVR immediately improved stereopsis in CRVO, albeit below normal levels. Stereopsis (not visual acuity) was associated with pre- and post-treatment VR-QOL in patients with CRVO.

scholarly journals Relationship Between Stereopsis and Vision-Related Quality of Life Following Intravitreal Ranibizumab Injections for Central Retinal Vein Occlusion

2021 ◽  
Author(s):  
Fumiki Okamoto ◽  
Mizuki Tomioka ◽  
Tomoya Murakami ◽  
Shohei Morikawa ◽  
Yoshimi Sugiura ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Visual Acuity ◽  
Retinal Vein Occlusion ◽  
Central Retinal Vein Occlusion ◽  
Post Treatment ◽  
Intravitreal Ranibizumab ◽  
Vein Occlusion ◽  
Related Quality ◽  
Central Retinal Vein

Abstract The study aimed to evaluate changes in stereopsis and vision-related quality of life (VR-QOL) in patients with central retinal vein occlusion (CRVO) following intravitreal ranibizumab injection (IVR) and investigate the relationship between stereopsis and VR-QOL. This study included 23 treatment-naïve patients with CRVO and 13 age-matched normal controls. Stereopsis, best-corrected visual acuity (BCVA), VR-QOL, and retinal microstructures were examined pre-treatment and 12 months post-treatment. The Titmus Stereo Test (TST) and TNO stereotest (TNO) were used to evaluate stereopsis. VR-QOL was evaluated using the 25-item National Eye Institute Visual Function Questionnaire (VFQ-25). IVR immediately and significantly improved the TST values, TNO values, composite VFQ-25 score, BCVA, and central foveal thickness in patients with CRVO. The 12-month post-treatment TST and TNO values were significantly worse in the CRVO group compared to those in the normal group. The baseline composite VFQ-25 score significantly correlated with the TST value. Multivariate analysis revealed significant associations between the 12-month post-treatment composite VFQ-25 score and the baseline and 12-month post-treatment TNO values. In conclusion, IVR immediately improved stereopsis in CRVO, albeit below normal levels. Stereopsis (not visual acuity) was associated with pre- and post-treatment VR-QOL in patients with CRVO.

Sign in / Sign up

Export Citation Format

Share Document